* Streamline Health Solutions Inc STRM.OQ STRM.O is
expected
to show a rise in quarterly revenue when it reports results on
December 13 for the period ending July 31 2023
* The Alpharetta Georgia-based company is expected to
report a
2.3% increase in revenue to $6.362 million from $6.22 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Streamline Health
Solutions
Inc is for a loss of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Streamline
Health
Solutions Inc is $1.25, above its last closing price of $0.31.
The company's guidance on September 14 2023 for the period ended
October 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of of USD0.
This summary was machine generated December 11 at 21:08 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)